Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,717.95 INR | +0.07% | +2.49% | +11.57% |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 421B | 447B | 526B | 632B | 709B | |||||
Other Revenues, Total | - | - | - | - | - | |||||
Total Revenues | 421B | 447B | 526B | 632B | 709B | |||||
Cost of Goods Sold, Total | 157B | 162B | 201B | 282B | 302B | |||||
Gross Profit | 265B | 285B | 325B | 350B | 407B | |||||
Selling General & Admin Expenses, Total | 124B | 126B | 143B | 168B | 190B | |||||
Depreciation & Amortization - (IS) | 26.65B | 25.91B | 26.18B | 28.11B | 30.83B | |||||
Other Operating Expenses | 47.96B | 43.97B | 66.7B | 76.66B | 88.35B | |||||
Other Operating Expenses, Total | 198B | 196B | 236B | 273B | 309B | |||||
Operating Income | 66.19B | 89.22B | 89.01B | 77.54B | 98.23B | |||||
Interest Expense, Total | -19.23B | -14.93B | -8.86B | -7.62B | -9.6B | |||||
Interest And Investment Income | 1.42B | 1.01B | 1.64B | 2.72B | 2.41B | |||||
Net Interest Expenses | -17.8B | -13.92B | -7.22B | -4.9B | -7.19B | |||||
Income (Loss) On Equity Invest. | -12.3M | 21.8M | 17M | 40.3M | 220M | |||||
Currency Exchange Gains (Loss) | 289M | 370M | -1.1B | 506M | 510M | |||||
Other Non Operating Income (Expenses) | 430M | 259M | 386M | 213M | 122M | |||||
EBT, Excl. Unusual Items | 49.09B | 75.95B | 81.09B | 73.41B | 91.9B | |||||
Merger & Related Restructuring Charges | - | - | - | - | -720M | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 3.71B | 5.74B | 2.89B | 976M | 3.04B | |||||
Gain (Loss) On Sale Of Assets | - | 41.1M | 32.2M | 3.4M | 6.7M | |||||
Asset Writedown | -375M | -546M | -369M | -226M | - | |||||
Insurance Settlements | - | - | - | - | - | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | -2.61B | - | - | - | |||||
EBT, Incl. Unusual Items | 52.42B | 78.58B | 83.64B | 74.16B | 94.22B | |||||
Income Tax Expense | -5.68B | 25.39B | 11.9B | 23.43B | 24.18B | |||||
Earnings From Continuing Operations | 58.1B | 53.19B | 71.74B | 50.73B | 70.04B | |||||
Earnings Of Discontinued Operations | 0 | 1.43B | 1.6B | - | - | |||||
Net Income to Company | 58.1B | 54.62B | 73.34B | 50.73B | 70.04B | |||||
Minority Interest | 43.8M | 12.5M | 100M | -94.4M | 10.4M | |||||
Net Income - (IS) | 58.15B | 54.63B | 73.44B | 50.64B | 70.05B | |||||
Net Income to Common Incl Extra Items | 58.15B | 54.63B | 73.44B | 50.64B | 70.05B | |||||
Net Income to Common Excl. Extra Items | 58.15B | 53.2B | 71.84B | 50.64B | 70.05B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 201.61 | 189.4 | 254.64 | 175.63 | 243.05 | |||||
Basic EPS - Continuing Operations | 201.61 | 184.44 | 249.09 | 175.63 | 243.05 | |||||
Basic Weighted Average Shares Outstanding | 288M | 288M | 288M | 288M | 288M | |||||
Net EPS - Diluted | 201.55 | 189.33 | 254.52 | 175.54 | 242.87 | |||||
Diluted EPS - Continuing Operations | 201.55 | 184.38 | 248.98 | 175.54 | 242.87 | |||||
Diluted Weighted Average Shares Outstanding | 289M | 289M | 289M | 288M | 288M | |||||
Normalized Basic EPS | 106.53 | 164.61 | 176.07 | 158.8 | 199.32 | |||||
Normalized Diluted EPS | 106.5 | 164.55 | 176 | 158.71 | 199.17 | |||||
Dividend Per Share | 13 | 37 | 38 | 38 | 70 | |||||
Payout Ratio | 5.42 | 6.86 | 14.5 | 21.55 | 15.62 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 91.48B | 114B | 114B | 104B | 128B | |||||
EBITA | 68.23B | 90.56B | 90.51B | 79.24B | 99.96B | |||||
EBIT | 66.19B | 89.22B | 89.01B | 77.54B | 98.23B | |||||
EBITDAR | 96.4B | 117B | 117B | 108B | 133B | |||||
Total Revenues (As Reported) | 428B | 455B | 531B | 637B | 715B | |||||
Effective Tax Rate - (Ratio) | -10.84 | 32.31 | 14.23 | 31.59 | 25.67 | |||||
Total Current Taxes | 9.17B | 14.15B | 15.16B | 20.71B | 22.18B | |||||
Total Deferred Taxes | -14.88B | 11.24B | -212M | 2.72B | 2B | |||||
Normalized Net Income | 30.73B | 47.48B | 50.78B | 45.79B | 57.45B | |||||
Interest Capitalized | 9.3M | 20.6M | 612M | 255M | 6.2M | |||||
Interest on Long-Term Debt | 501M | 497M | 652M | 634M | 632M | |||||
Non-Cash Pension Expense | -3.3M | 31.9M | -38.9M | -49.5M | -47.9M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | - | - | - | - | |||||
Selling and Marketing Expenses | 97.25B | 100B | 117B | 140B | 159B | |||||
General and Administrative Expenses | - | - | - | - | - | |||||
Research And Development Expense From Footnotes | 163M | 152M | 117M | 116M | 154M | |||||
Net Rental Expense, Total | 4.92B | 2.43B | 2.99B | 3.7B | 5.02B | |||||
Imputed Operating Lease Interest Expense | 3.07B | 1.26B | 1.37B | 2.08B | 3.44B | |||||
Imputed Operating Lease Depreciation | 1.86B | 1.18B | 1.62B | 1.61B | 1.59B | |||||
Maintenance & Repair Expenses, Total | 9B | 8.44B | - | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | 168M | 121M | 240M | 356M | 431M | |||||
Total Stock-Based Compensation | 168M | 121M | 240M | 356M | 431M |